| Host: |
Rabbit |
| Applications: |
IHC/IF |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Dynein axonemal heavy chain 5 (2445-2495 aa) is suitable for use in Immunohistochemistry and Immunofluorescence research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IHC-P 1:50-200IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
DNAH5 |
| Gene ID: |
1767 |
| Uniprot ID: |
DYH5_HUMAN |
| Immunogen Region: |
2445-2495 aa |
| Specificity: |
This antibody detects endogenous levels of DYH5 at Human/Mouse |
| Immunogen: |
Synthesized peptide derived from the human DYH5 at the amino acid range 2445-2495 |
| Function | Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity.the force-producing power stroke is thought to occur on release of ADP. Required for structural and functional integrity of the cilia of ependymal cells lining the brain ventricles. |
| Protein Name | Dynein Axonemal Heavy Chain 5Axonemal Beta Dynein Heavy Chain 5Ciliary Dynein Heavy Chain 5 |
| Cellular Localisation | CytoplasmCytoskeletonCilium Axoneme |
| Alternative Antibody Names | Anti-Dynein Axonemal Heavy Chain 5 antibodyAnti-Axonemal Beta Dynein Heavy Chain 5 antibodyAnti-Ciliary Dynein Heavy Chain 5 antibodyAnti-DNAH5 antibodyAnti-DNAHC5 antibodyAnti-HL1 antibodyAnti-KIAA1603 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
